多种病原体变异和多种疫苗情况下疫苗有效性指标的时间特性
Temporal Properties of Vaccine Effectiveness Measures in Presence of Multiple Pathogen Variants and Multiple Vaccines
摘要:
疫苗有效性(VE)通常定义为发病率比、累积风险比或比值比。已知基于发生率比的VE在研究期间对于漏效疫苗是时不变的,并且基于累积风险比的VE对于全效或无效疫苗是时不变的。因此,建议将这些VE措施分别作为泄漏疫苗和全或无疫苗的适当VE措施。然而,在具有多种病原体变体和多种疫苗的疾病中,研究者还可能对疫苗的变体特异性VE、疫苗针对两种变体的相对VE或不同疫苗针对给定变体的相对VE感兴趣。在这种多变量和多疫苗的情况下,上述VE措施的时间特性尚未完全研究。此外,没有通用的样本量计算器可用于估计变异体特异性VE或相对VE的研究。作为一种解决方案,我们定义了变异特异性和相对VE措施,同时考虑到多种竞争性病原体变异。然后,我们提出了一个通用的模式,在多变量设置的全或无疫苗的行动。随后,我们评估的条件和各种VE措施可以随时间变化的程度。我们表明,每个VE措施是随时间变化的全或无作用疫苗在多变量和多疫苗的情况下。对于泄漏的疫苗,我们表明,所有的措施以外的发病率比的基础上是随时间变化的。我们讨论了VE研究的背景下,常用的队列,累积病例对照,和测试阴性的研究设计,这些结果的实际意义。最后,对于多变异和多疫苗的情况下,我们实现了样本量计算的变异特异性和相对VE中的R包和在线计算器。
英文摘要:
Vaccine effectiveness (VE) is typically defined as incidence rate ratio, cumulative-risk ratio, or odds ratio. The VE based on incidence rate ratio is known to be time-invariant over the study period for leaky action vaccines and, the VE based on cumulative-risk ratio is time-invariant for all-or-none action vaccines. Consequently, these VE measures are recommended as appropriate measures of VE for leaky and all-or-none vaccines, respectively. However, in diseases with multiple pathogen variants and multiple vaccines, investigators may also be interested in variant-specific VE of a vaccine, the relative VE of a vaccine against two variants, or the relative VE of different vaccines against a given variant. In this multi-variant and multi-vaccine scenario, the temporal properties of the aforementioned VE measures have not been studied entirely yet. Furthermore, no general-purpose sample size calculator is available for either studies that intend to estimate variant-specific VE or relative VE. As a solution, we define variant-specific and relative VE measures while accounting for multiple competing pathogen variants. We then propose a generic mode of action for all-or-none vaccines in a multi-variant setting. Subsequently, we evaluate the conditions and the extent to which various VE measures can be time-varying. We show that every VE measure is time-varying for all-or-none action vaccines in a multi-variant and multi-vaccine scenario. For leaky vaccines, we show that all measures other than those based on incidence rate ratios are time-varying. We discuss the practical implications of these results on VE studies in the context of the commonly used cohort, cumulative case-control, and test-negative study designs. Lastly, for the multi-variant and multi-vaccine scenario, we implement sample size calculations for both variant-specific and relative VE in an R package and an online calculator.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。